Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: mRNA

NIAID to Launch Major Clinical Trial Investigating Severe Allergic Reactions with COVID-19 Vaccines from Moderna & Pfizer/BioNTech

As TrialSite has monitored allergic vaccine reactions associated with mRNA-based COVID-19 vaccines under U.S. Food and Drug Administration (FDA) emergency […]

NIAID to Launch Major Clinical Trial Investigating Severe Allergic Reactions with COVID-19 Vaccines from Moderna & PfizerBioNTech
6 days ago
Share

Moderna Announces Strategies & Updates Associated with Variant-Specific Vaccine while Forecasting $18.4b in Revenue

Moderna Inc. (Nasdaq: MRNA), the biotechnology company with one of the authorized vaccines for COVID-19, completed the manufacturing of clinical […]

Moderna Announces Strategies & Updates Associated with Variant-Specific Vaccine while Forecasting $18.4b in Revenue
1 week ago
Share

TrialSite COVID-19 Vaccine Candidate Update

On Thursday Johnson & Johnson filed for an EUA with the FDA after reporting compelling preliminary results from its large […]

4 weeks ago
Share

TGA Provides 2-Year Provisional Approval for Pfizer COVID-19 Vaccine: First Such Approval in Australia

Australia’s drug regulator, the Therapeutic Goods Administration (TGA), granted a provisional approval to Pfizer Australia Pty Ltd for its COVID-19 […]

TGA Provides 2-Year Provisional Approval for Pfizer COVID-19 Vaccine First Such Approval in Australia
1 month ago
Share

Bayer Moves Forcefully into COVID-19 Vaccine Development Race Inking Deal with CureVac to Progress CVnCoV

Bayer, Germany’s largest pharmaceutical company, inked a deal with CureVac in a bid to accelerate a new class of transformative medicines […]

Bayer Moves Forcefully into COVID-19 Vaccine Development Race Inking Deal with CureVac to Progress CVnCoV
2 months ago
Share

Australian Gov. Funds $10.1m in Clinical Trials including New mRNA-based Vaccine out of University of Melbourne

In response to the COVID-19 pandemic, biotech firms have embraced the use of mRNA (messenger ribonucleic acid) technology, disrupting vaccine […]

Australian Gov. Funds $10.1m in Clinical Trials including New mRNA-based Vaccine out of University of Melbourne
2 months ago
Share

University of Iowa VTEU Initiates Phase 3 Novavax Clinical Trial Investigating COVID-19 Vaccine

The University of Iowa Health Care (UIHC) gains a more prominent role as a trial site hub investigating COVID-19 investigational […]

University of Iowa VTEU Initiates Phase 3 Novavax Clinical Trial Investigating COVID-19 Vaccine
2 months ago
Share

CureVac Prepares to Treat Volunteers in Phase 3 mRNA-based Vaccine Trial at University Medical Center Mainz

Germany’s CureVac N.V. (Nasdaq: CVAC) a globally focused biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic […]

CureVac Prepares to Treat Volunteers in Phase 3 mRNA-based Vaccine Trial at University Medical Center Mainz
3 months ago
Share

FDA Investigating Reports of Allergic Involving the Pfizer Vaccine Across the Nation

As larger groups of people get vaccinated with the Pfizer/BioNTech vaccine for COVID-19, the U.S. Food and Drug Administration (FDA) […]

FDA Investigating Reports of Allergic Involving the Pfizer Vaccine Across the Nation
3 months ago
Share

‘Light at the End of the Tunnel’ as IC Nurse the First to be Vaccinated Nationwide at Northwell

In a well publicized event, Northwell Health, New York State’s largest provider of hospitals, health centers and clinics made history […]

‘Light at the End of the Tunnel’ as IC Nurse the First to be Vaccinated Nationwide at Northwell
3 months ago
Share

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.